mRNA vaccines

LEXINGTON, Mass., July 24, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences Holdings, PBC (NASDAQ: GRNA) (“GreenLight” or the “Company”) today announced the closing of its previously announced merger with SW MergerCo, Inc. (“Merger Sub”)…

New York, United States, June 08, 2023 (GLOBE NEWSWIRE) -- mRNA-based therapeutics and vaccines permit the combination of desirable immunological properties. These are manufactured in the laboratory using mammalian cells and injected…

<!-- Name:DistributionId Value:8844764 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value: -->…

<!-- Name:DistributionId Value:8740831 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value: -->…

London, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “mRNA Synthesis and mRNA Manufacturing Services Market (2nd Edition), 2022–2035” report to its list of offerings. Owing to the recent success and…

The initial phase one clinical data shows the vaccine has strong levels of neutralising antibodies, similar to approved mRNA vaccines, but at up to a 10-fold lower dose in the first 10 individuals. A COVID-19 vaccine booster aimed at…

The research, published in the journal Nature, may help design vaccines and antibody treatments that will be effective against not only Omicron but other variants that may emerge in the future. Scientists have identified antibodies that…

The research project will boost the UK’s and the world’s ability to rapidly develop new vaccines in response to new variants of COVID-19 and also future pandemics. Researchers in the UK are using new ways to rapidly develop and mass…

This was more than two months after the first mRNA vaccines, and some others, proved their mettle in clinical trials, but before their impact on the pandemic was fully clear, said Goran Hansson, secretary-general of the Royal Swedish…